United Arab Emirates Cardiac Sutures Market Size & Outlook, 2026-2034
United Arab Emirates Cardiac Sutures Market Insights
- As per Reed Intelligence insights, the United Arab Emirates Cardiac Sutures Market stood at USD 72.56 Million in 2025 and is anticipated to grow to USD 156.5 Million by 2034.
- The United Arab Emirates market is expected to advance at a CAGR of 8.81% from 2026 through 2034.
- In 2025, Absorbable Sutures accounted for the highest share of the Product Type market size.
- During the forecast period, Absorbable Sutures is set to register the highest growth, making it the most lucrative Product Type segment.
![United Arab Emirates Cardiac Sutures Market Size, Share & Growth Analysis By [2034]](https://reedintelligence.com/uploads/charts/united-arab-emirates-cardiac-sutures-market-united-arab-emirates-product-type-199956.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United Arab Emirates accounted for 5.11% of the global Cardiac Sutures Market size in 2025.
- By 2034, United States is expected to remain the top global market in terms of size.
- Within Middle East and Africa, United Arab Emirates is forecasted to dominate the regional Cardiac Sutures Market size by 2034.
- United Arab Emirates will be the fastest-growing market in Middle East and Africa, projected to achieve USD 155.16 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 72.56 Million |
| Market Size In 2034 | USD 156.5 Million |
| Largest segment | Absorbable Sutures |
| Units | Revenue in USD Million |
| CAGR | 8.81% (2026-2034) |
| Segmnetation Covered | |
| Product Type |
|
| Application |
|
| End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Arab Emirates Cardiac Sutures Market Product Type 2026-2034 (USD Million)
| Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Absorbable Sutures | XX.x | XX.x | XX.x | 28.27 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-Absorbable Sutures | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Antimicrobial-Coated Sutures | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Braided Sutures | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Monofilament Sutures | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Cardiac Sutures Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiac Valve Surgery | XX.x | XX.x | XX.x | 32.24 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Coronary Artery Bypass Grafting | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Congenital Heart Defect Repair | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Heart Transplantation | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Minimally Invasive Cardiac Surgery | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Cardiac Sutures Market End Use 2026-2034 (USD Million)
| End Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 29.45 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgical Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty Cardiac Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Academic and Research Institutes | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.